Beacon Financial Strategies CORP

Position in BEAM — Beam Therapeutics Inc.

CIK 2084239 RALEIGH, NC

Position in BEAM

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$337,605

New position

Shares Held

9,837

first reported quarter

Ownership

0.010%

of shares outstanding

% of Portfolio

2.24%

of 13F equity value

Holder Rank

#161

of 274 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Beacon Financial Strategies CORP holds $341,881 across 4 Biotechnology names. BEAM ranks #1 (98.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BEAM	Beam Therapeutics Inc. This page	9,837	$337,605
2	FTRE	Fortrea Holdings Inc.	130	$2,262
3	DTIL	Precision Biosciences Inc	172	$1,351
4	HUMA	Humacyte, Inc.	850	$663

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$337,605	9,837	—	Shares	Sole	2026-07-08
No filing history on record for this holder in this stock.